Aspirin: Recent developments

Cellular and Molecular Life Sciences

Volumn 65, Issue 3, 2008, Pages 354-358

  Yasuda, O ^a   Takemura, Y ^a   Kawamoto, H ^a   Rakugi, H ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aspirin; Atherosclerosis; Cyclooxygenase; Lipoxin; Nitric oxide; Nuclear factor B

Indexed keywords

ACETYLSALICYLIC ACID;

ANTIOXIDANT ACTIVITY; ARTERY DISEASE; ATHEROSCLEROSIS; BRAIN INFARCTION; CLINICAL TRIAL; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG RESEARCH; HEART INFARCTION; HEART PROTECTION; HUMAN; INFLAMMATION; ISCHEMIA; LOW DRUG DOSE; NEOPLASM; OXIDATIVE STRESS; SHORT SURVEY; THROMBOCYTE FUNCTION; TREATMENT FAILURE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COLORECTAL NEOPLASMS; CYCLOOXYGENASE INHIBITORS; HUMANS; INFLAMMATION; PAIN; PLATELET AGGREGATION INHIBITORS;

EID: 39149093456     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7449-4     Document Type: Short Survey

References (51)

1. Miner, J. and Hoffhines, A. (2007) The discovery of aspirin's antithrombotic effects. Tex. Heart Inst. J. 34, 179-186.
2. Diener, H. C., Cunha, L., Forbes, C., Sivenius, J., Smets, P. and Lowenthal, A. (1996) European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J. Neurol. Sci. 143, 1-13.
3. Baigent, C., Collins, R., Appleby, P., Parish, S., Sleight, P. and Peto, R. (1998) ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. BMJ 316, 1337-1343.
4. The SALT Collaborative Group (1991) Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 338, 1345-1349.
5. Farrell, B., Godwin, J., Richards, S. and Warlow, C. (1991) The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J. Neurol. Neurosurg. Psychiatry 54, 1044-1054.
6. Breyer, R. M., Kennedy, C. R., Zhang, Y. and Breyer, M. D. (2000) Structure-function analyses of eicosanoid receptors: physiologic and therapeutic implications. Ann. NY. Acad. Sci. 905, 221-231.
7. Smith, W. L., DeWitt, D. L. and Garavito, R. M. (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145-182.
8. Kuwano, T., Nakao, S., Yamamoto, H., Tsuneyoshi, M., Yamamoto, T., Kuwano, M. and Ono, M. (2004) Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J. 18, 300-310.
9. Rocca, B., Secchiero, P., Ciabattoni, G., Ranelletti, F. O., Catani, L., Guidotti, L., Melloni, E., Maggiano, N., Zauli, G., Patrono, C. (2002) Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc. Natl. Acad. Sci. USA 99, 7634-7639.
10. Patrignani, P., Filabozzi, P. and Patrono, C. (1982) Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J. Clin. Invest. 69, 1366-1372.
11. FitzGerald, G. A., Oates, J. A., Hawiger, J., Maas, R. L., Roberts, L. J., 2nd, Lawson, J. A. and Brash, A. R. (1983) Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J. Clin. Invest. 71, 676-688.
12. Ross, R. (1999) Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-126.
13. Davignon, J. and Ganz, P. (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109, III27-III32.
14. Fuster, V., Moreno, P. R., Fayad, Z. A., Corti, R. and Badimon, J. J. (2005) Atherothrombosis and high-risk plaque. I. Evolving concepts. J. Am. Coll. Cardiol. 46, 937-954.
15. Schwartz, S. M., deBlois, D. and O'Brien, E. R. (1995) The intima: soil for atherosclerosis and restenosis. Circ. Res. 77, 445-465.
16. Hansson, G. K., Holm, J. and Jonasson, L. (1989) Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135, 169-175.
17. Sakai, A., Kume, N., Nishi, E., Tanoue, K., Miyasaka, M. and Kita, T. (1997) P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes. Arterioscler. Thromb. Vasc. Biol. 17, 310-316.
18. Poston, R. N., Haskard, D. O., Coucher, J. R., Gall, N. P. and Johnson-Tidey, R. R. (1992) Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 140, 665-673.
19. O'Brien, K. D., McDonald, T. O., Chait, A., Allen, M. D. and Alpers, C. E. (1996) Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93, 672-682.
20. Montgomery, K. F., Osborn, L., Hession, C., Tizard, R., Goff, D., Vassallo, C., Tarr, P. I., Bomsztyk, K., Lobb, R., Harlan, J. M., Pohlman, T. H. (1991) Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA 88, 6523-6527.
21. Pierce, J. W., Read, M. A., Ding, H., Luscinskas, F. W. and Collins, T. (1996) Salicylates inhibit I kappa B-alpha phosphorylation, endothelial- leukocyte adhesion molecule expression, and neutrophil transmigration. J. Immunol. 156, 3961-3969.
22. Weber, C., Erl, W., Pietsch, A. and Weber, P. C. (1995) Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 91, 1914-1917.
23. Gerli, R., Gresele, P., Bistoni, O., Paolucci, C., Lanfrancone, L., Fiorucci, S., Muscat, C. and Costantini, V. (2001) Salicylates inhibit T cell adhesion on endothelium under nonstatic conditions: induction of L-selectin shedding by a tyrosine kinase-dependent mechanism. J. Immunol. 166, 832-840.
24. Yotsui, T., Yasuda, O., Kawamoto, H., Higuchi, M., Chihara, Y., Umemoto, E., Tanaka, T., Miyasaka, M., Rakugi, H., Ogihara, T. (2007) Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cells. FEBS Lett. 581, 427-432.
25. Kopp, E. and Ghosh, S. (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265, 956-959.
26. Fawcett, T. W., Xu, Q. and Holbrook, N. J. (1997) Potentiation of heat stress-induced hsp70 expression in vivo by aspirin. Cell Stress Chaperones 2, 104-109.
27. Xu, X. M., Sansores-Garcia, L., Chen, X. M., Matijevic-Aleksic, N., Du, M. and Wu, K. K. (1999) Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc. Natl. Acad. Sci. U S A 96, 5292-5297.
28. Serhan, C. N. and Chiang, N. (2002) Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins. ScientificWorldJournal 2, 169-204.
29. Claria, J., Lee, M. H. and Serhan, C. N. (1996) Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol. Med. 2, 583-596.
30. Takano, T., Fiore, S., Maddox, J. F., Brady, H. R., Petasis, N. A. and Serhan, C. N. (1997) Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185, 1693-1704.
31. Fiore, S., Maddox, J. F., Perez, H. D. and Serhan, C. N. (1994) Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 180, 253-260.
32. Gronert, K., Martinsson-Niskanen, T., Ravasi, S., Chiang, N. and Serhan, C. N. (2001) Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. Am. J. Pathol. 158, 3-9.
33. McMahon, B., Stenson, C., McPhillips, F., Fanning, A., Brady, H. R. and Godson, C. (2000) Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells: differential activation of MAP kinases through distinct receptors. J. Biol. Chem. 275, 27566-27575.
34. Taubert, D., Berkels, R., Grosser, N., Schroder, H., Grundemann, D. and Schomig, E. (2004) Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. Br. J. Pharmacol. 143, 159-165.
35. Paul-Clark, M. J., Van Cao, T., Moradi-Bidhendi, N., Cooper, D. and Gilroy, D. W. (2004) 15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J. Exp. Med. 200, 69-78.
36. Topper, J. N., Cai, J., Falb, D. and Gimbrone, M. A., Jr. (1996) Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc. Natl. Acad. Sci. USA 93, 10417-10422.
37. Chiang, N., Bermudez, E. A., Ridker, P. M., Hurwitz, S. and Serhan, C. N. (2004) Aspirin triggers antiinflammatory 15-epilipoxin A4 and inhibits thromboxane in a randomized human trial. Proc. Natl. Acad. Sci. USA 101, 15178-15183.
38. Grosser, N. and Schroder, H. (2003) Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway. Arterioscler. Thromb. Vasc. Biol. 23, 1345-1351.
39. Grosser, N., Abate, A., Oberle, S., Vreman, H. J., Dennery, P. A., Becker, J. C., Pohle, T., Seidman, D. S., Schroder, H. (2003) Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem. Biophys. Res. Commun. 308, 956-960.
40. Nascimento-Silva, V., Arruda, M. A., Barja-Fidalgo, C. and Fierro, I. M. (2007) Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism. Thromb. Haemost. 97, 88-98.
41. Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324, 71-86.
42. Hovens, M. M., Snoep, J. D., Eikenboom, J. C., van der Bom, J. G., Mertens, B. J. and Huisman, M. V. (2007) Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review. Am. Heart J. 153, 175-181.
43. Halushka, M. K., Walker, L. P. and Halushka, P. V. (2003) Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin. Pharmacol. Ther. 73, 122-130.
44. Cattaneo, M. (2007) Laboratory detection of 'aspirin resistance': what test should we use (if any)? Eur. Heart J. 28, 1673-1675.
45. Yang, V. W., Shields, J. M., Hamilton, S. R., Spannhake, E. W., Hubbard, W. C., Hylind, L. M., Robinson, C. R. and Giardiello, F. M. (1998) Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res. 58, 1750-1753.
46. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., Taketo, M. M. (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-809.
47. Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M. and Taketo, M. M. (2001) Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat. Med. 7, 1048-1051.
48. Baron, J. A., Cole, B. F., Sandler, R. S., Haile, R. W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R. W., Rothstein, R., Burke, C. A., Snover, D. C., Church, T. R., Allen, J. I., Beach, M., Beck, G. J., Bond, J. H., Byers, T., Greenberg, E. R., Mandel, J. S., Marcon, N., Mott, L. A., Pearson, L., Saibil, F., van Stolk, R. U. (2003) A randomized trial of aspirin to prevent colorectal adenomas. N. Engl. J. Med. 348, 891-899.
49. Benamouzig, R., Deyra, J., Martin, A., Girard, B., Jullian, E., Piednoir, B., Couturier, D., Coste, T., Little, J., Chaussade, S. (2003) Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 125, 328-336.
50. Benelli, R. (2007) Aspirin, COX-2, and the risk of colorectal cancer. N. Engl. J. Med. 357, 824-825; author reply 824-825.
51. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P. and Hennekens, C. H. (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336, 973-979.